載入...
MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway
BACKGROUND: Mesenchymal stem cells (MSCs) are favourable treatments for ischaemic diseases; however, MSCs from diabetic patients are not useful for this purpose. Recent studies have shown that the expression of miR-34a is significantly increased in patients with hyperglycaemia; the precise role of m...
Na minha lista:
| 發表在: | Stem Cell Res Ther |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7866658/ https://ncbi.nlm.nih.gov/pubmed/33546760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02183-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|